kw1	kw2	pg	crit_p	edge_weight	inv_edge_weight	R1C1	iteration
abdominal pain/chemically induced	antineoplastic agents immunological/therapeutic use	0.0005888664151666	0.0013888221509739	0.032258064516129	0.830190299122522	1	0
abdominal pain/chemically induced	disease progression	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
abdominal pain/chemically induced	enterocolitis/chemically induced	9.62073753996151e-11	1.01979817923592e-09	0.021505376344086	0.830190299122522	1	0
abdominal pain/chemically induced	gastritis/complications	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
abdominal pain/chemically induced	glucocorticoids/therapeutic use	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
abdominal pain/chemically induced	neoplasms/drug therapy	0.0046517769353922	0.008650672897396	0.129032258064516	0.830190299122522	1	0
ACAD8	carcinoma non-small-cell lung/complications	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	colon/drug effects	0.0033230272463853	0.0063786076318945	0.0638148667601683	0.830190299122522	1	0
ACAD8	CRP	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	drug-related side effects and adverse reactions	3.63207168585511e-06	2.07484813671004e-05	0.0427769985974754	0.830190299122522	1	0
ACAD8	immune checkpoint inhibitors/pharmacology	0.0007650097159677	0.001771405992799	0.0846189808321645	0.830190299122522	1	0
ACAD8	infliximab/administration & dosage	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	melanoma/complications	0.0005782582526319	0.0013705798087225	0.0638148667601683	0.830190299122522	1	0
ACAD8	mesalamine/pharmacology	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	protective agents/pharmacology	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	trinitrobenzenesulfonic acid/adverse effects	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
ACAD8	urothelium/drug effects	2.89640156303506e-09	2.14198999312825e-08	0.021505376344086	0.830190299122522	1	0
adenocarcinoma of lung/drug therapy	b7-h1 antigen/antagonists & inhibitors	8.48877190762209e-10	7.74320237197327e-09	0.032258064516129	0.830190299122522	1	0
adenocarcinoma of lung/drug therapy	biomarkers/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
adenocarcinoma of lung/drug therapy	glycoproteins/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	beclomethasone/adverse effects	1.25266463868456e-12	1.86725322703918e-11	0.032258064516129	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	biological products/therapeutic use	1.25266463868456e-12	1.86725322703918e-11	0.032258064516129	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	1.37004461520096e-06	8.16889101813573e-06	0.002805049088359	0.347909608055624	3	0
adrenal cortex hormones/therapeutic use	inflammation/drug therapy	0.0004982368131516	0.0011838553418347	0.0638148667601683	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	skin neoplasms/drug therapy	0.0002334339983105	0.0005814517869145	0.0638148667601683	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	SNCA	0.0009302340538402	0.0021230700654632	0.0946781129109319	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	TNF	0.0012219719371479	0.0026891839170452	0.0946781129109319	0.830190299122522	1	0
adrenal cortex hormones/therapeutic use	tumor necrosis factor inhibitors	2.25073886195304e-08	1.50681043810751e-07	0.032258064516129	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	colitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	encephalitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	hepatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	myocarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	neoplasms/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	pancreatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal gland diseases/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	angiogenesis inhibitors/therapeutic use	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	axitinib/administration & dosage	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	bevacizumab/administration & dosage	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	carcinoma renal cell/drug therapy	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
adrenal insufficiency/chemically induced	diabetes mellitus type 1/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	exanthema/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
adrenal insufficiency/chemically induced	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
adrenal insufficiency/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
adrenal insufficiency/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
AHR	IL22	1.42881040332554e-10	1.49789574150832e-09	0.021505376344086	0.830190299122522	1	0
AHR	immune checkpoint inhibitors/pharmacology	8.48877190762209e-10	7.74320237197327e-09	0.043010752688172	0.830190299122522	1	0
AHR	neoplasms/drug therapy	0.0001112700446812	0.0003281348458297	0.129032258064516	0.830190299122522	1	0
AHR	tryptophan/pharmacology	0	0	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	axitinib/administration & dosage	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	bevacizumab/administration & dosage	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	carcinoma renal cell/drug therapy	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	diabetes mellitus type 1/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	exanthema/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
angiogenesis inhibitors/therapeutic use	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/adverse effects	clostridium infections/chemically induced	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/adverse effects	escherichia coli infections/drug therapy	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/adverse effects	neoplasms/drug therapy	0.0012043173595439	0.0026891839170452	0.129032258064516	0.830190299122522	1	0
anti-bacterial agents/adverse effects	virus diseases/etiology	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/pharmacology	antineoplastic agents immunological/adverse effects	0.0001577274046907	0.0004491699823134	0.075268817204301	0.830190299122522	1	0
anti-bacterial agents/pharmacology	colitis/etiology	6.54831243673826e-08	4.30833797561952e-07	0.021505376344086	0.830190299122522	1	0
anti-bacterial agents/pharmacology	dysbiosis/etiology	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/pharmacology	host microbial interactions/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/pharmacology	metabolome/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
anti-bacterial agents/pharmacology	neoplasms/complications	5.79199854744417e-09	4.18603531383465e-08	0.032258064516129	0.830190299122522	1	0
antibodies monoclonal humanized	endometrial neoplasms/drug therapy	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized	neoplasm recurrence local/drug therapy	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/administration & dosage	dose-response relationship drug	2.16207951542202e-09	1.64352498622519e-08	0.021505376344086	0.830190299122522	1	0
antibodies monoclonal humanized/administration & dosage	drugs investigational/administration & dosage	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/administration & dosage	immune checkpoint inhibitors/administration & dosage	0.0017670866860923	0.0037694605453253	0.043010752688172	0.830190299122522	1	0
antibodies monoclonal humanized/administration & dosage	neoplasms/diagnosis	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/administration & dosage	pneumonia/chemically induced	9.10500023044714e-05	0.0002777578837603	0.032258064516129	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	immunocompromised host	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	immunosuppressive agents/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	melanoma/immunology	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	myasthenia gravis/diagnosis	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	prednisone/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/adverse effects	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal humanized/therapeutic use	infliximab/adverse effects	6.36879438076221e-12	9.068402745145e-11	0.043010752688172	0.830190299122522	1	0
antibodies monoclonal humanized/therapeutic use	steroids/adverse effects	0	0	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal/adverse effects	antineoplastic agents immunological/adverse effects	0.0029295317826157	0.0057564846974571	0.075268817204301	0.830190299122522	1	0
antibodies monoclonal/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.000426487876034	0.0010339756892922	0.032258064516129	0.830190299122522	1	0
antibodies monoclonal/adverse effects	lymphocytes/drug effects	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal/adverse effects	melanoma/complications	2.84150786487025e-05	0.0001046640348681	0.032258064516129	0.830190299122522	1	0
antibodies monoclonal/adverse effects	neutrophils/drug effects	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
antibodies monoclonal/adverse effects	vitamin d/administration & dosage	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	colitis ulcerative/chemically induced	0.0009302340538402	0.0021230700654632	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.0011131493251242	0.0025284391813537	0.0141870751968928	0.584635003932401	2	0
antineoplastic agents immunological/adverse effects	cytomegalovirus infections/diagnosis	5.06331199190413e-09	3.71569203098195e-08	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	dysbiosis/etiology	0.0001577274046907	0.0004491699823134	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	hashimoto disease/chemically induced	0.0009302340538402	0.0021230700654632	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	host microbial interactions/drug effects	0.0001577274046907	0.0004491699823134	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	immune checkpoint inhibitors/adverse effects	0.0053254060985574	0.0097794752993721	0.016270764526575	0.010308700389748	7	0
antineoplastic agents immunological/adverse effects	lymphocytes/drug effects	0.0029295317826157	0.0057564846974571	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	metabolome/drug effects	0.0001577274046907	0.0004491699823134	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	neutrophils/drug effects	0.0029295317826157	0.0057564846974571	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	paclitaxel/therapeutic use	0.0009302340538402	0.0021230700654632	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.0049629267011769	0.0092203156239976	0.012719967331643	0.347909608055624	3	0
antineoplastic agents immunological/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.0009302340538402	0.0021230700654632	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	tongue neoplasms/drug therapy	0.0009302340538402	0.0021230700654632	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	vitamin d	4.50371576143915e-07	2.87394303438993e-06	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/adverse effects	vitamin d/administration & dosage	0.0029295317826157	0.0057564846974571	0.075268817204301	0.830190299122522	1	0
antineoplastic agents immunological/therapeutic use	disease progression	0.0005888664151666	0.0013888221509739	0.032258064516129	0.830190299122522	1	0
antineoplastic agents immunological/therapeutic use	enterocolitis/chemically induced	0.0031884016641496	0.0061761120560381	0.0638148667601683	0.830190299122522	1	0
antineoplastic agents immunological/therapeutic use	gastritis/complications	0.0005888664151666	0.0013888221509739	0.032258064516129	0.830190299122522	1	0
antineoplastic agents immunological/therapeutic use	glucocorticoids/therapeutic use	0.0005888664151666	0.0013888221509739	0.032258064516129	0.830190299122522	1	0
APC	ARG1	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	azoxymethane/adverse effects	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	b7-h1 antigen/genetics	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	colonic neoplasms/drug therapy	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	colorectal neoplasms/drug therapy	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	dextran sulfate/adverse effects	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	gene expression regulation neoplastic	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	ht29 cells	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	immune checkpoint inhibitors/administration & dosage	0.0022669618381826	0.0045434487261055	0.0014025245441795	0.584635003932401	2	0
APC	interleukin-17/genetics	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	lymphocytes tumor-infiltrating/metabolism	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	micrornas/genetics	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	MIR15B	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	myeloid-derived suppressor cells/metabolism	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	NRF1	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	PARP1	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	phthalazines/administration & dosage	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	piperazines/administration & dosage	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	t-lymphocytes cytotoxic/immunology	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
APC	TIPARP	0.0028052417422615	0.005535058163635	0.021505376344086	0.830190299122522	1	0
APC	tumor microenvironment/drug effects	0.0052154676801927	0.0095868134237069	0.021505376344086	0.830190299122522	1	0
ARG1	azoxymethane/adverse effects	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	cell line tumor	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
ARG1	colonic neoplasms/drug therapy	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	dextran sulfate/adverse effects	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
ARG1	myeloid-derived suppressor cells/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	PARP1	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ARG1	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
arthritis/chemically induced	CHI3L1	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
arthritis/chemically induced	CXCL8	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
arthritis/chemically induced	glucocorticoids	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
arthritis/chemically induced	IL17A	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
arthritis/chemically induced	IL6	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
arthritis/chemically induced	nivolumab/therapeutic use	1.91866149846787e-05	7.23479474125828e-05	0.021505376344086	0.830190299122522	1	0
axitinib/administration & dosage	bevacizumab/administration & dosage	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	carcinoma renal cell/drug therapy	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
axitinib/administration & dosage	diabetes mellitus type 1/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	exanthema/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
axitinib/administration & dosage	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
axitinib/administration & dosage	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
axitinib/administration & dosage	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	cell line tumor	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
azoxymethane/adverse effects	colonic neoplasms/drug therapy	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	dextran sulfate/adverse effects	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
azoxymethane/adverse effects	myeloid-derived suppressor cells/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	PARP1	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
azoxymethane/adverse effects	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/antagonists & inhibitors	biomarkers/metabolism	8.48877190762209e-10	7.74320237197327e-09	0.032258064516129	0.830190299122522	1	0
b7-h1 antigen/antagonists & inhibitors	CD274	0.0002239297954592	0.0005814517869145	0.0035063113604488	0.347909608055624	3	0
b7-h1 antigen/antagonists & inhibitors	colitis/epidemiology	8.48877190762209e-10	7.74320237197327e-09	0.032258064516129	0.830190299122522	1	0
b7-h1 antigen/antagonists & inhibitors	glycoproteins/metabolism	8.48877190762209e-10	7.74320237197327e-09	0.032258064516129	0.830190299122522	1	0
b7-h1 antigen/antagonists & inhibitors	neoplasms/complications	0.0007148389160953	0.0016572450205467	0.0946781129109319	0.830190299122522	1	0
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.0023776856511018	0.0047603611986383	0.0187722515913259	0.584635003932401	2	0
b7-h1 antigen/genetics	colorectal neoplasms/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	gene expression regulation neoplastic	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	ht29 cells	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	IL17A	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
b7-h1 antigen/genetics	interleukin-17/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	lymphocytes tumor-infiltrating/metabolism	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/genetics	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/metabolism	colitis/diagnosis	1.56541446472147e-14	3.1774582964772e-13	0.021505376344086	0.830190299122522	1	0
b7-h1 antigen/metabolism	gastrointestinal tract/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
b7-h1 antigen/metabolism	immune checkpoint inhibitors/pharmacology	2.36599509539914e-07	1.53548253129985e-06	0.043010752688172	0.830190299122522	1	0
b7-h1 antigen/metabolism	inflammatory bowel diseases	1.95732319241415e-13	3.011752138005e-12	0.021505376344086	0.830190299122522	1	0
b7-h1 antigen/metabolism	programmed cell death 1 receptor/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
beclomethasone/adverse effects	diarrhea/chemically induced	0.001239801514261	0.0027158912620093	0.150537634408602	0.830190299122522	1	0
beclomethasone/adverse effects	inflammation/drug therapy	1.69131375571396e-11	1.90948322242736e-10	0.021505376344086	0.830190299122522	1	0
bevacizumab/administration & dosage	carcinoma renal cell/drug therapy	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
bevacizumab/administration & dosage	diabetes mellitus type 1/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	exanthema/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
bevacizumab/administration & dosage	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
bevacizumab/administration & dosage	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
bevacizumab/administration & dosage	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
biological products/therapeutic use	diarrhea/chemically induced	0.001239801514261	0.0027158912620093	0.150537634408602	0.830190299122522	1	0
biological products/therapeutic use	neoplasms/drug therapy	0.0001112700446812	0.0003281348458297	0.129032258064516	0.830190299122522	1	0
biomarkers/analysis	colitis/drug therapy	2.25073886195304e-08	1.50681043810751e-07	0.032258064516129	0.830190299122522	1	0
biomarkers/analysis	diarrhea/chemically induced	0.0033916470872356	0.0064907348469864	0.150537634408602	0.830190299122522	1	0
biomarkers/analysis	feces/chemistry	0	0	0.010752688172043	0.830190299122522	1	0
biomarkers/analysis	leukocyte l1 antigen complex/analysis	0	0	0.010752688172043	0.830190299122522	1	0
biomarkers/analysis	neoplasms/drug therapy	0.0004436759846442	0.0010715617451913	0.129032258064516	0.830190299122522	1	0
biomarkers/metabolism	glycoproteins/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
BTLA	CD28	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	CSF2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	gastrointestinal neoplasms/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	HAVCR2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	IL15	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
BTLA	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
BTLA	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
BTLA	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
butyrates/metabolism	neoplasms/drug therapy	4.86148063361114e-07	3.07142551289074e-06	0.129032258064516	0.830190299122522	1	0
carcinoma non-small-cell lung	cd8-positive t-lymphocytes	0	0	0.010752688172043	0.830190299122522	1	0
carcinoma non-small-cell lung	immune checkpoint inhibitors	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	CRP	0	0	0.010752688172043	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	drug-related side effects and adverse reactions	4.16946477344027e-11	4.59846172700811e-10	0.021505376344086	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	immune checkpoint inhibitors/administration & dosage	0.000872653019809	0.0020084704002361	0.043010752688172	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	infliximab/administration & dosage	0	0	0.010752688172043	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	melanoma/complications	8.11373358056144e-07	4.85297920743299e-06	0.032258064516129	0.830190299122522	1	0
carcinoma non-small-cell lung/complications	urothelium/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
carcinoma non-small-cell lung/drug therapy	ipilimumab/therapeutic use	7.1540639148715e-05	0.0002585218551055	0.0638148667601683	0.830190299122522	1	0
carcinoma non-small-cell lung/drug therapy	pneumonia/chemically induced	0.0002123977946096	0.0005814517869145	0.0638148667601683	0.830190299122522	1	0
carcinoma renal cell/drug therapy	diabetes mellitus type 1/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	exanthema/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	fatigue/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	hepatitis autoimmune/etiology	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	hypophysitis/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	inflammatory bowel diseases/drug therapy	0.0012219719371479	0.0026891839170452	0.0638148667601683	0.830190299122522	1	0
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	3.41405953174778e-07	2.19327460827433e-06	0.0007012622720897	0.584635003932401	2	0
carcinoma renal cell/drug therapy	myasthenia gravis/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	myocarditis/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	nephritis/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	proton pump inhibitors/adverse effects	3.61856766772917e-10	3.71195005915443e-09	0.021505376344086	0.830190299122522	1	0
carcinoma renal cell/drug therapy	pruritus/chemically induced	0.0012219719371479	0.0026891839170452	0.021505376344086	0.830190299122522	1	0
CD274	CTLA4	0.0020080863838891	0.0040587169708268	0.0003490778454898	0.010308700389748	7	0
CD274	PDCD1	0.0005382898811121	0.0012774341954751	1.55572732193422e-07	2.38197855033722e-06	13	0
CD28	CSF2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	gastrointestinal neoplasms/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	HAVCR2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	IL15	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
CD28	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
CD28	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD28	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CD4	CD68	1.88182802673964e-13	2.99210656251603e-12	0.0002337540906965	0.584635003932401	2	0
CD4	cd8-positive t-lymphocytes/drug effects	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
CD4	CD8A	0.0002095106790775	0.0005814517869145	0.0023375409069658	0.584635003932401	2	0
CD4	colitis ulcerative/immunology	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
CD4	crohn disease/immunology	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD4	graft vs host disease/immunology	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD4	inflammatory bowel diseases/drug therapy	0.0002334339983105	0.0005814517869145	0.0638148667601683	0.830190299122522	1	0
CD4	macrophages/drug effects	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD4	phenotype	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
CD68	cd8-positive t-lymphocytes/drug effects	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
CD68	CD8A	0.0002095106790775	0.0005814517869145	0.0023375409069658	0.584635003932401	2	0
CD68	colitis ulcerative/immunology	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
CD68	crohn disease/immunology	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD68	graft vs host disease/immunology	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD68	inflammatory bowel diseases/drug therapy	0.0002334339983105	0.0005814517869145	0.0638148667601683	0.830190299122522	1	0
CD68	macrophages/drug effects	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
CD68	phenotype	0.0012219719371479	0.0026891839170452	0.0427769985974754	0.830190299122522	1	0
cd8-positive t-lymphocytes	immune checkpoint inhibitors	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	chemokines/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	colitis/drug therapy	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	gene expression regulation/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	inflammation/drug therapy	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	melanoma/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	multigene family	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/cytology	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	CD8A	0.0013552885133465	0.0029452055620332	0.0023375409069658	0.584635003932401	2	0
cd8-positive t-lymphocytes/drug effects	colitis ulcerative/immunology	1.40216387389813e-08	9.94826330498929e-08	0.0002337540906965	0.584635003932401	2	0
cd8-positive t-lymphocytes/drug effects	colon/drug effects	1.42285160453781e-06	8.30214330721145e-06	0.0007012622720897	0.584635003932401	2	0
cd8-positive t-lymphocytes/drug effects	crohn disease/immunology	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	graft vs host disease/immunology	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	immunologic memory/drug effects	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	interferon-gamma/metabolism	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	macrophages/drug effects	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	phenotype	1.40216387389813e-08	9.94826330498929e-08	0.0002337540906965	0.584635003932401	2	0
cd8-positive t-lymphocytes/drug effects	piperidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
cd8-positive t-lymphocytes/drug effects	pyrimidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	cell line tumor	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	colitis/etiology	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	cytotoxicity immunologic	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	drug-related side effects and adverse reactions/prevention & control	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	growth inhibitors/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	immune checkpoint inhibitors/therapeutic use	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	lymphocytes tumor-infiltrating/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	MTOR	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cd8-positive t-lymphocytes/immunology	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
CD8A	colitis ulcerative/immunology	0.0013552885133465	0.0029452055620332	0.0023375409069658	0.584635003932401	2	0
CD8A	phenotype	0.0013552885133465	0.0029452055620332	0.0023375409069658	0.584635003932401	2	0
cell line tumor	colonic neoplasms/drug therapy	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	cytotoxicity immunologic	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	dextran sulfate/adverse effects	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	drug synergism	2.30042179798495e-05	8.62319212289841e-05	0.0002337540906965	0.584635003932401	2	0
cell line tumor	drug-related side effects and adverse reactions/prevention & control	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	growth inhibitors/therapeutic use	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	lymphocytes tumor-infiltrating/immunology	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	MTOR	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	myeloid-derived suppressor cells/metabolism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	PARP1	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	phosphatidylinositol 3-kinases/metabolism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	phthalazines/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	piperazines/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	sirolimus/therapeutic use	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cell line tumor	TIPARP	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
chemical and drug induced liver injury/diagnosis	neoplasms/drug therapy	4.86148063361114e-07	3.07142551289074e-06	0.129032258064516	0.830190299122522	1	0
chemokines/metabolism	colitis/drug therapy	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
chemokines/metabolism	ctla-4 antigen/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	gene expression regulation/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	inflammation/drug therapy	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
chemokines/metabolism	melanoma/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	multigene family	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
chemokines/metabolism	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
CHI3L1	CXCL8	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
CHI3L1	glucocorticoids	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
CHI3L1	IL17A	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
CHI3L1	IL6	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
CHI3L1	nivolumab/therapeutic use	1.91866149846787e-05	7.23479474125828e-05	0.021505376344086	0.830190299122522	1	0
clostridium infections/chemically induced	escherichia coli infections/drug therapy	0	0	0.010752688172043	0.830190299122522	1	0
clostridium infections/chemically induced	neoplasms/drug therapy	0.0012043173595439	0.0026891839170452	0.129032258064516	0.830190299122522	1	0
clostridium infections/chemically induced	virus diseases/etiology	0	0	0.010752688172043	0.830190299122522	1	0
colitis	CTLA4	0.0045640144008352	0.0085206844195631	0.0795123530046391	0.584635003932401	2	0
colitis	diarrhea	0	0	0.0014025245441795	0.584635003932401	2	0
colitis	immune checkpoint inhibitors	6.68308462309364e-05	0.000242420636138	0.0969899665551839	0.347909608055624	3	0
colitis	inflammatory bowel diseases	5.56643996285633e-06	3.17037834302384e-05	0.0846189808321645	0.830190299122522	1	0
colitis	inflammatory bowel diseases/drug therapy	0.0002334339983105	0.0005814517869145	0.124855509147234	0.830190299122522	1	0
colitis	ligands	9.62073753996151e-11	1.01979817923592e-09	0.043010752688172	0.830190299122522	1	0
colitis	neoplasms	2.73582738142819e-05	0.0001015556156374	0.163750819851802	0.830190299122522	1	0
colitis	pneumonia	9.62073753996151e-11	1.01979817923592e-09	0.043010752688172	0.830190299122522	1	0
colitis	recurrence	1.25266463868456e-12	1.86725322703918e-11	0.043010752688172	0.830190299122522	1	0
colitis collagenous/drug therapy	immune checkpoint inhibitors/pharmacology	6.36879438076221e-12	9.068402745145e-11	0.043010752688172	0.830190299122522	1	0
colitis collagenous/drug therapy	melanoma/complications	2.20490292690556e-12	3.23611906502755e-11	0.032258064516129	0.830190299122522	1	0
colitis collagenous/drug therapy	skin neoplasms/complications	0	0	0.010752688172043	0.830190299122522	1	0
colitis microscopic/chemically induced	immune checkpoint inhibitors	8.11341549500355e-10	7.74320237197327e-09	0.101683029453015	0.584635003932401	2	0
colitis microscopic/chemically induced	inflammatory bowel diseases/complications	0	0	0.0427769985974754	0.830190299122522	1	0
colitis ulcerative	immune checkpoint inhibitors	3.02429414844596e-10	3.11910985688373e-09	0.32258064516129	0.830190299122522	1	0
colitis ulcerative/chemically induced	hashimoto disease/chemically induced	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
colitis ulcerative/chemically induced	nivolumab/adverse effects	0.0036027646835737	0.0067591691408641	0.129032258064516	0.830190299122522	1	0
colitis ulcerative/chemically induced	paclitaxel/therapeutic use	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
colitis ulcerative/chemically induced	SNCA	2.03116920582946e-06	1.16731049539838e-05	0.032258064516129	0.830190299122522	1	0
colitis ulcerative/chemically induced	squamous cell carcinoma of head and neck/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
colitis ulcerative/chemically induced	tongue neoplasms/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
colitis ulcerative/drug therapy	crohn disease/drug therapy	0	0	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/drug therapy	interleukin-12/antagonists & inhibitors	0	0	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/drug therapy	interleukin-23/antagonists & inhibitors	0	0	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/drug therapy	ustekinumab/therapeutic use	0	0	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	colon/drug effects	1.42285160453781e-06	8.30214330721145e-06	0.0007012622720897	0.584635003932401	2	0
colitis ulcerative/immunology	crohn disease/immunology	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	graft vs host disease/immunology	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	immunologic memory/drug effects	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	interferon-gamma/metabolism	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	macrophages/drug effects	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
colitis ulcerative/immunology	phenotype	1.40216387389813e-08	9.94826330498929e-08	0.0002337540906965	0.584635003932401	2	0
colitis ulcerative/immunology	piperidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
colitis ulcerative/immunology	pyrimidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
colitis ulcerative/physiopathology	crohn disease/physiopathology	0	0	0.010752688172043	0.830190299122522	1	0
colitis ulcerative/physiopathology	enterocolitis/chemically induced	0	0	0.021505376344086	0.830190299122522	1	0
colitis/chemically induced	immune checkpoint inhibitors	3.34409855997642e-05	0.0001229391146904	0.814358314952549	8.37008936595782e-13	21	0
colitis/chemically induced	immune checkpoint inhibitors/adverse effects	6.64030541791538e-05	0.0002413276711882	0.28552761772611	1e-15	41	0
colitis/chemically induced	ipilimumab/adverse effects	0.0007075612536729	0.0016423684574307	0.0589207356081562	0.0008903144156418	9	0
colitis/chemically induced	neoplasms/drug therapy	0.0017136073625698	0.0037111950599129	0.126233984373546	5.36975220686589e-05	11	0
colitis/chemically induced	nivolumab/adverse effects	0.0041246524905659	0.0077230980883216	0.351518422440415	0.0002278681042509	10	0
colitis/diagnosis	disease susceptibility	0	0	0.021505376344086	0.830190299122522	1	0
colitis/diagnosis	gastrointestinal tract/metabolism	1.56541446472147e-14	3.1774582964772e-13	0.021505376344086	0.830190299122522	1	0
colitis/diagnosis	immune checkpoint inhibitors/pharmacology	4.23227637775803e-05	0.0001541065520756	0.0846189808321645	0.830190299122522	1	0
colitis/diagnosis	inflammatory bowel diseases	5.06331199190413e-09	3.71569203098195e-08	0.0427769985974754	0.830190299122522	1	0
colitis/diagnosis	postoperative complications	0	0	0.021505376344086	0.830190299122522	1	0
colitis/diagnosis	programmed cell death 1 receptor/metabolism	1.56541446472147e-14	3.1774582964772e-13	0.021505376344086	0.830190299122522	1	0
colitis/diagnostic imaging	encephalitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	hepatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	myocarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	neoplasms/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
colitis/diagnostic imaging	pancreatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
colitis/drug therapy	ctla-4 antigen/immunology	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	diarrhea/therapy	1.88737914186277e-15	3.9572740688727e-14	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	feces/chemistry	2.25073886195304e-08	1.50681043810751e-07	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	gene expression regulation/genetics	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	inflammation/drug therapy	0.0028052417422615	0.005535058163635	0.0638148667601683	0.830190299122522	1	0
colitis/drug therapy	leukocyte l1 antigen complex/analysis	2.25073886195304e-08	1.50681043810751e-07	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	melanoma/genetics	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	multigene family	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	myeloid cells/cytology	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	neoplasms/therapy	1.88737914186277e-15	3.9572740688727e-14	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	receptors antigen t-cell/genetics	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	receptors cxcr3/genetics	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	receptors cxcr6/genetics	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/drug therapy	t-lymphocytes regulatory/cytology	0.0004982368131516	0.0011838553418347	0.032258064516129	0.830190299122522	1	0
colitis/epidemiology	neoplasms/complications	3.02429414844596e-10	3.11910985688373e-09	0.032258064516129	0.830190299122522	1	0
colitis/epidemiology	programmed cell death 1 receptor/antagonists & inhibitors	0.0026251685810957	0.0052393531932329	0.086021505376344	0.830190299122522	1	0
colitis/etiology	cytotoxicity immunologic	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	drug-related side effects and adverse reactions/prevention & control	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	dysbiosis/etiology	6.54831243673826e-08	4.30833797561952e-07	0.021505376344086	0.830190299122522	1	0
colitis/etiology	growth inhibitors/therapeutic use	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	host microbial interactions/drug effects	6.54831243673826e-08	4.30833797561952e-07	0.021505376344086	0.830190299122522	1	0
colitis/etiology	lymphocytes tumor-infiltrating/immunology	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	metabolome/drug effects	6.54831243673826e-08	4.30833797561952e-07	0.021505376344086	0.830190299122522	1	0
colitis/etiology	MTOR	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	neoplasms/complications	0.0012943475198039	0.0028224172203267	0.0638148667601683	0.830190299122522	1	0
colitis/etiology	phosphatidylinositol 3-kinases/metabolism	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/etiology	sirolimus/therapeutic use	0.000267839978386	0.0006602566909052	0.021505376344086	0.830190299122522	1	0
colitis/therapy	immune checkpoint inhibitors	9.99540715695968e-06	4.04909487377475e-05	0.32258064516129	0.830190299122522	1	0
colitis/therapy	immunologic factors	0	0	0.021505376344086	0.830190299122522	1	0
colon/diagnostic imaging	drug resistance/immunology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
colon/diagnostic imaging	glucocorticoids/pharmacology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
colon/diagnostic imaging	immunosuppressive agents/pharmacology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
colon/diagnostic imaging	infliximab/adverse effects	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
colon/diagnostic imaging	intestinal mucosa/diagnostic imaging	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
colon/diagnostic imaging	melanoma/drug therapy	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
colon/diagnostic imaging	mucositis/chemically induced	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
colon/diagnostic imaging	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
colon/drug effects	crohn disease/immunology	0.0001660054582111	0.0004664777824253	0.032258064516129	0.830190299122522	1	0
colon/drug effects	graft vs host disease/immunology	0.0001660054582111	0.0004664777824253	0.032258064516129	0.830190299122522	1	0
colon/drug effects	immunologic memory/drug effects	0.0010372325214909	0.0023588076889209	0.032258064516129	0.830190299122522	1	0
colon/drug effects	interferon-gamma/metabolism	0.0010372325214909	0.0023588076889209	0.032258064516129	0.830190299122522	1	0
colon/drug effects	macrophages/drug effects	0.0001660054582111	0.0004664777824253	0.032258064516129	0.830190299122522	1	0
colon/drug effects	mesalamine/pharmacology	2.34397230222116e-05	8.71793207141907e-05	0.032258064516129	0.830190299122522	1	0
colon/drug effects	phenotype	1.42285160453781e-06	8.30214330721145e-06	0.0007012622720897	0.584635003932401	2	0
colon/drug effects	protective agents/pharmacology	2.34397230222116e-05	8.71793207141907e-05	0.032258064516129	0.830190299122522	1	0
colon/drug effects	trinitrobenzenesulfonic acid/adverse effects	2.34397230222116e-05	8.71793207141907e-05	0.032258064516129	0.830190299122522	1	0
colon/immunology	intestinal mucosa/immunology	0	0	0.021505376344086	0.830190299122522	1	0
colon/immunology	neoplasms/drug therapy	1.63239910477841e-09	1.25589414996662e-08	0.0154277699859747	0.584635003932401	2	0
colon/immunology	t-lymphocyte subsets/immunology	0	0	0.021505376344086	0.830190299122522	1	0
colonic neoplasms/drug therapy	dextran sulfate/adverse effects	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
colonic neoplasms/drug therapy	myeloid-derived suppressor cells/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	PARP1	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colonic neoplasms/drug therapy	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	gene expression regulation neoplastic	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	ht29 cells	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	IL17A	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
colorectal neoplasms/drug therapy	interleukin-17/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	lymphocytes tumor-infiltrating/metabolism	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
colorectal neoplasms/drug therapy	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
crohn disease/drug therapy	immune checkpoint inhibitors	9.99540715695968e-06	4.04909487377475e-05	0.32258064516129	0.830190299122522	1	0
crohn disease/immunology	graft vs host disease/immunology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
crohn disease/immunology	macrophages/drug effects	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
crohn disease/immunology	phenotype	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
crohn disease/physiopathology	enterocolitis/chemically induced	0	0	0.021505376344086	0.830190299122522	1	0
CRP	drug-related side effects and adverse reactions	4.16946477344027e-11	4.59846172700811e-10	0.021505376344086	0.830190299122522	1	0
CRP	immune checkpoint inhibitors/administration & dosage	0.000872653019809	0.0020084704002361	0.043010752688172	0.830190299122522	1	0
CRP	infliximab/administration & dosage	0	0	0.010752688172043	0.830190299122522	1	0
CRP	melanoma/complications	8.11373358056144e-07	4.85297920743299e-06	0.032258064516129	0.830190299122522	1	0
CRP	urothelium/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
CSF2	gastrointestinal neoplasms/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	HAVCR2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	IL15	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
CSF2	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
CSF2	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
CSF2	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0025224336864024	0.0050448673728049	0.0016953593391181	0.347909608055624	3	0
ctla-4 antigen/antagonists & inhibitors	immunologic memory/drug effects	0.0012578068210133	0.0027490210933488	0.032258064516129	0.830190299122522	1	0
ctla-4 antigen/antagonists & inhibitors	interferon-gamma/metabolism	0.0012578068210133	0.0027490210933488	0.032258064516129	0.830190299122522	1	0
ctla-4 antigen/antagonists & inhibitors	lymphocytes/drug effects	0.000426487876034	0.0010339756892922	0.032258064516129	0.830190299122522	1	0
ctla-4 antigen/antagonists & inhibitors	neutrophils/drug effects	0.000426487876034	0.0010339756892922	0.032258064516129	0.830190299122522	1	0
ctla-4 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.0004806528722617	0.0011594003543304	0.0004315460135936	0.347909608055624	3	0
ctla-4 antigen/antagonists & inhibitors	vitamin d/administration & dosage	0.000426487876034	0.0010339756892922	0.032258064516129	0.830190299122522	1	0
ctla-4 antigen/immunology	gene expression regulation/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	inflammation/drug therapy	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
ctla-4 antigen/immunology	melanoma/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	multigene family	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
ctla-4 antigen/immunology	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
CTLA4	inflammatory bowel diseases/drug therapy	0.0045640144008352	0.0085206844195631	0.042892591279688	0.584635003932401	2	0
CTLA4	PDCD1	0.001293939617514	0.0028224172203267	7.40082614672845e-07	5.36975220686589e-05	11	0
CXCL10	CXCL9	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL10	dermatitis	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL10	psoriasis	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL10	rna	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL10	TCIM	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL10	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
CXCL8	glucocorticoids	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
CXCL8	IL17A	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
CXCL8	IL6	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
CXCL8	nivolumab/therapeutic use	1.91866149846787e-05	7.23479474125828e-05	0.021505376344086	0.830190299122522	1	0
CXCL9	dermatitis	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL9	psoriasis	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL9	rna	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL9	TCIM	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
CXCL9	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
cytomegalovirus infections/complications	immune checkpoint inhibitors	9.99540715695968e-06	4.04909487377475e-05	0.32258064516129	0.830190299122522	1	0
cytotoxicity immunologic	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
cytotoxicity immunologic	drug-related side effects and adverse reactions/prevention & control	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cytotoxicity immunologic	growth inhibitors/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cytotoxicity immunologic	immune checkpoint inhibitors/therapeutic use	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
cytotoxicity immunologic	lymphocytes tumor-infiltrating/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cytotoxicity immunologic	MTOR	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cytotoxicity immunologic	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
cytotoxicity immunologic	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dermatitis	psoriasis	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
dermatitis	rna	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
dermatitis	TCIM	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
dermatitis	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
dextran sulfate/adverse effects	drug synergism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
dextran sulfate/adverse effects	myeloid-derived suppressor cells/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dextran sulfate/adverse effects	PARP1	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dextran sulfate/adverse effects	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dextran sulfate/adverse effects	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dextran sulfate/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
dextran sulfate/adverse effects	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	exanthema/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
diabetes mellitus type 1/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
diarrhea	immune checkpoint inhibitors	5.90933778177316e-06	3.35565966893547e-05	0.101683029453015	0.584635003932401	2	0
diarrhea	inflammatory bowel diseases	1.95732319241415e-13	3.011752138005e-12	0.0427769985974754	0.830190299122522	1	0
diarrhea	neoplasms	1.04816155754861e-11	1.48140166800204e-10	0.0846189808321645	0.830190299122522	1	0
diarrhea	recurrence	0	0	0.021505376344086	0.830190299122522	1	0
diarrhea/chemically induced	feces	0.001239801514261	0.0027158912620093	0.150537634408602	0.830190299122522	1	0
diarrhea/chemically induced	feces/chemistry	0.0033916470872356	0.0064907348469864	0.150537634408602	0.830190299122522	1	0
diarrhea/chemically induced	leukocyte l1 antigen complex/analysis	0.0033916470872356	0.0064907348469864	0.150537634408602	0.830190299122522	1	0
diarrhea/chemically induced	LTF	0.001239801514261	0.0027158912620093	0.150537634408602	0.830190299122522	1	0
diarrhea/chemically induced	neoplasms/drug therapy	6.95203111253928e-05	0.0002516978247196	0.0161314791677859	0.0777468263617441	5	0
diarrhea/therapy	immune checkpoint inhibitors	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
diarrhea/therapy	neoplasms/therapy	0	0	0.010752688172043	0.830190299122522	1	0
disease progression	enterocolitis/chemically induced	9.62073753996151e-11	1.01979817923592e-09	0.021505376344086	0.830190299122522	1	0
disease progression	gastritis/complications	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
disease progression	glucocorticoids/therapeutic use	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
disease progression	neoplasms/drug therapy	0.0046517769353922	0.008650672897396	0.129032258064516	0.830190299122522	1	0
disease susceptibility	nivolumab/adverse effects	8.27983542073252e-06	3.54050817950207e-05	0.129032258064516	0.830190299122522	1	0
disease susceptibility	postoperative complications	0	0	0.010752688172043	0.830190299122522	1	0
dose-response relationship drug	drugs investigational/administration & dosage	2.16207951542202e-09	1.64352498622519e-08	0.021505376344086	0.830190299122522	1	0
dose-response relationship drug	feces	7.7715611723761e-16	1.66608300189816e-14	0.021505376344086	0.830190299122522	1	0
dose-response relationship drug	neoplasms/diagnosis	2.16207951542202e-09	1.64352498622519e-08	0.021505376344086	0.830190299122522	1	0
dose-response relationship drug	pneumonia/chemically induced	0.0019308727447	0.0040050466235307	0.0638148667601683	0.830190299122522	1	0
dose-response relationship drug	steroids/therapeutic use	2.0925394750293e-10	2.18172968216169e-09	0.0427769985974754	0.830190299122522	1	0
drug resistance/immunology	glucocorticoids/pharmacology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
drug resistance/immunology	immunosuppressive agents/pharmacology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
drug resistance/immunology	infliximab/adverse effects	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
drug resistance/immunology	intestinal mucosa/diagnostic imaging	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
drug resistance/immunology	melanoma/drug therapy	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
drug resistance/immunology	mucositis/chemically induced	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
drug resistance/immunology	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
drug synergism	drug-related side effects and adverse reactions/prevention & control	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	growth inhibitors/therapeutic use	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	lymphocytes tumor-infiltrating/immunology	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	MTOR	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	myeloid-derived suppressor cells/metabolism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	PARP1	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	phosphatidylinositol 3-kinases/metabolism	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	phthalazines/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	piperazines/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	sirolimus/therapeutic use	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug synergism	TIPARP	0.0019794334203299	0.0040050466235307	0.021505376344086	0.830190299122522	1	0
drug-related side effects and adverse reactions	infliximab/administration & dosage	4.16946477344027e-11	4.59846172700811e-10	0.021505376344086	0.830190299122522	1	0
drug-related side effects and adverse reactions	infliximab/adverse effects	0.0001746066731989	0.0004899257830345	0.0846189808321645	0.830190299122522	1	0
drug-related side effects and adverse reactions	melanoma/complications	0.000124270133592	0.0003619960532727	0.0638148667601683	0.830190299122522	1	0
drug-related side effects and adverse reactions	melanoma/drug therapy	0.0010372325214909	0.0023588076889209	0.105189340813464	0.830190299122522	1	0
drug-related side effects and adverse reactions	TNF	0.000124270133592	0.0003619960532727	0.0638148667601683	0.830190299122522	1	0
drug-related side effects and adverse reactions	urothelium/drug effects	4.16946477344027e-11	4.59846172700811e-10	0.021505376344086	0.830190299122522	1	0
drug-related side effects and adverse reactions/diagnosis	ipilimumab/adverse effects	2.16563430855965e-05	8.14996106653217e-05	0.0967741935483871	0.830190299122522	1	0
drug-related side effects and adverse reactions/diagnosis	nivolumab/adverse effects	0.0003058560984983	0.0007520276236272	0.129032258064516	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	growth inhibitors/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	immune checkpoint inhibitors/therapeutic use	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	lymphocytes tumor-infiltrating/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	MTOR	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
drug-related side effects and adverse reactions/prevention & control	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
drugs investigational/administration & dosage	immune checkpoint inhibitors/administration & dosage	0.0017670866860923	0.0037694605453253	0.043010752688172	0.830190299122522	1	0
drugs investigational/administration & dosage	neoplasms/diagnosis	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
drugs investigational/administration & dosage	pneumonia/chemically induced	9.10500023044714e-05	0.0002777578837603	0.032258064516129	0.830190299122522	1	0
dysbiosis/etiology	host microbial interactions/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
dysbiosis/etiology	metabolome/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
dysbiosis/etiology	neoplasms/complications	5.79199854744417e-09	4.18603531383465e-08	0.032258064516129	0.830190299122522	1	0
encephalitis/diagnostic imaging	hepatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	myocarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	neoplasms/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
encephalitis/diagnostic imaging	pancreatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
encephalitis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
endometrial neoplasms/drug therapy	neoplasm recurrence local/drug therapy	0	0	0.010752688172043	0.830190299122522	1	0
enterocolitis/chemically induced	gastritis/complications	9.62073753996151e-11	1.01979817923592e-09	0.021505376344086	0.830190299122522	1	0
enterocolitis/chemically induced	glucocorticoids/therapeutic use	9.62073753996151e-11	1.01979817923592e-09	0.021505376344086	0.830190299122522	1	0
escherichia coli infections/drug therapy	neoplasms/drug therapy	0.0012043173595439	0.0026891839170452	0.129032258064516	0.830190299122522	1	0
escherichia coli infections/drug therapy	virus diseases/etiology	0	0	0.010752688172043	0.830190299122522	1	0
esophagitis	immune checkpoint inhibitors	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
esophagitis	ulcer/chemically induced	0	0	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	fatigue/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
exanthema/chemically induced	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
exanthema/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
exanthema/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	hepatitis autoimmune/etiology	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
fatigue/chemically induced	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
fatigue/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
fatigue/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
feces	steroids/therapeutic use	0	0	0.021505376344086	0.830190299122522	1	0
feces/chemistry	leukocyte l1 antigen complex/analysis	0	0	0.010752688172043	0.830190299122522	1	0
feces/chemistry	neoplasms/drug therapy	0.0004436759846442	0.0010715617451913	0.129032258064516	0.830190299122522	1	0
gastritis/complications	glucocorticoids/therapeutic use	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
gastritis/complications	neoplasms/drug therapy	0.0046517769353922	0.008650672897396	0.129032258064516	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	HAVCR2	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL15	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal neoplasms/drug therapy	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gastrointestinal tract/metabolism	immune checkpoint inhibitors/pharmacology	2.36599509539914e-07	1.53548253129985e-06	0.043010752688172	0.830190299122522	1	0
gastrointestinal tract/metabolism	inflammatory bowel diseases	1.95732319241415e-13	3.011752138005e-12	0.021505376344086	0.830190299122522	1	0
gastrointestinal tract/metabolism	programmed cell death 1 receptor/metabolism	0	0	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	ht29 cells	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	IL17A	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
gene expression regulation neoplastic	interleukin-17/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	lymphocytes tumor-infiltrating/metabolism	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation neoplastic	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	inflammation/drug therapy	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
gene expression regulation/genetics	melanoma/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	multigene family	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gene expression regulation/genetics	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
gentian violet	inflammation	0	0	0.010752688172043	0.830190299122522	1	0
glucocorticoids	IL17A	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
glucocorticoids	IL6	1.3102028466272e-05	5.06045957766131e-05	0.021505376344086	0.830190299122522	1	0
glucocorticoids	nivolumab/therapeutic use	1.91866149846787e-05	7.23479474125828e-05	0.021505376344086	0.830190299122522	1	0
glucocorticoids/pharmacology	immunosuppressive agents/pharmacology	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
glucocorticoids/pharmacology	infliximab/adverse effects	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
glucocorticoids/pharmacology	intestinal mucosa/diagnostic imaging	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
glucocorticoids/pharmacology	melanoma/drug therapy	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
glucocorticoids/pharmacology	mucositis/chemically induced	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
glucocorticoids/pharmacology	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
glucocorticoids/therapeutic use	neoplasms/drug therapy	0.0046517769353922	0.008650672897396	0.129032258064516	0.830190299122522	1	0
graft vs host disease/immunology	macrophages/drug effects	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
graft vs host disease/immunology	phenotype	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
growth inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
growth inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
growth inhibitors/therapeutic use	MTOR	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
growth inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
growth inhibitors/therapeutic use	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
hashimoto disease/chemically induced	nivolumab/adverse effects	0.0036027646835737	0.0067591691408641	0.129032258064516	0.830190299122522	1	0
hashimoto disease/chemically induced	paclitaxel/therapeutic use	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
hashimoto disease/chemically induced	SNCA	2.03116920582946e-06	1.16731049539838e-05	0.032258064516129	0.830190299122522	1	0
hashimoto disease/chemically induced	squamous cell carcinoma of head and neck/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
hashimoto disease/chemically induced	tongue neoplasms/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
HAVCR2	IL15	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
HAVCR2	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
HAVCR2	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
HAVCR2	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
HAVCR2	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
HAVCR2	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
HAVCR2	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
HAVCR2	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
hepatitis autoimmune/etiology	hypophysitis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hepatitis autoimmune/etiology	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
hepatitis autoimmune/etiology	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hepatitis autoimmune/etiology	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hepatitis autoimmune/etiology	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hepatitis autoimmune/etiology	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
hepatitis autoimmune/etiology	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnosis	neoplasms/drug therapy	4.86148063361114e-07	3.07142551289074e-06	0.129032258064516	0.830190299122522	1	0
hepatitis/diagnostic imaging	myocarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnostic imaging	neoplasms/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
hepatitis/diagnostic imaging	pancreatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
hepatitis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
host microbial interactions/drug effects	metabolome/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
host microbial interactions/drug effects	neoplasms/complications	5.79199854744417e-09	4.18603531383465e-08	0.032258064516129	0.830190299122522	1	0
ht29 cells	IL17A	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
ht29 cells	interleukin-17/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	lymphocytes tumor-infiltrating/metabolism	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
ht29 cells	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
hypophysitis/chemically induced	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
hypophysitis/chemically induced	myasthenia gravis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hypophysitis/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hypophysitis/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
hypophysitis/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
hypophysitis/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
IL15	IL17C	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL15	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL15	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL15	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL15	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL15	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL15	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL17A	interleukin-17/genetics	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	lymphocytes tumor-infiltrating/metabolism	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	micrornas/genetics	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	MIR15B	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	NRF1	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	t-lymphocytes cytotoxic/immunology	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17A	tumor microenvironment/drug effects	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17C	IL21	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL17C	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL17C	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL17C	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL17C	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL17C	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL21	IL22	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL21	IL4	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL21	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL21	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL21	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL22	IL4	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL22	immune checkpoint inhibitors/pharmacology	0.0045271389450379	0.0084684128501298	0.0846189808321645	0.830190299122522	1	0
IL22	immune system diseases/drug therapy	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL22	LIF	0.0006439898318757	0.0014984543892913	0.021505376344086	0.830190299122522	1	0
IL22	tryptophan/pharmacology	1.42881040332554e-10	1.49789574150832e-09	0.021505376344086	0.830190299122522	1	0
IL4	IL6	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL4	immune system diseases/drug therapy	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL4	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
IL6	immune system diseases/drug therapy	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
IL6	LIF	0.0017899010765538	0.0037694605453253	0.021505376344086	0.830190299122522	1	0
immune checkpoint inhibitors	immunologic factors	8.11341549500355e-10	7.74320237197327e-09	0.101683029453015	0.584635003932401	2	0
immune checkpoint inhibitors	lung neoplasms	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
immune checkpoint inhibitors	neoplasms	0.0025310276064748	0.0050567546315748	0.387959866220736	0.584635003932401	2	0
immune checkpoint inhibitors	neoplasms/therapy	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
immune checkpoint inhibitors	prednisolone/therapeutic use	0.0021298880586121	0.0043003454135787	0.32258064516129	0.830190299122522	1	0
immune checkpoint inhibitors	TNF	0.0006526577599305	0.0015167734542599	0.0312870859855432	0.347909608055624	3	0
immune checkpoint inhibitors	ulcer/chemically induced	0.0003476938855124	0.0008472540658465	0.32258064516129	0.830190299122522	1	0
immune checkpoint inhibitors/administration & dosage	infliximab/administration & dosage	0.000872653019809	0.0020084704002361	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/administration & dosage	neoplasms/diagnosis	0.0017670866860923	0.0037694605453253	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/administration & dosage	urothelium/drug effects	0.000872653019809	0.0020084704002361	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	7.30735188636533e-05	0.0002635619546159	0.0079594183628137	5.36975220686589e-05	11	0
immune checkpoint inhibitors/adverse effects	nivolumab/adverse effects	0.0016934163344379	0.0036716345069405	0.149573662209081	0.0008903144156418	9	0
immune checkpoint inhibitors/pharmacology	inflammatory bowel diseases	9.10500023044714e-05	0.0002777578837603	0.0846189808321645	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	mesalamine/pharmacology	1.3929446125438e-06	8.22829201465502e-06	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	programmed cell death 1 receptor/metabolism	2.36599509539914e-07	1.53548253129985e-06	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	protective agents/pharmacology	1.3929446125438e-06	8.22829201465502e-06	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	skin neoplasms/complications	6.36879438076221e-12	9.068402745145e-11	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	trinitrobenzenesulfonic acid/adverse effects	1.3929446125438e-06	8.22829201465502e-06	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/pharmacology	tryptophan/pharmacology	8.48877190762209e-10	7.74320237197327e-09	0.043010752688172	0.830190299122522	1	0
immune checkpoint inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
immune checkpoint inhibitors/therapeutic use	MTOR	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
immune checkpoint inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
immune checkpoint inhibitors/therapeutic use	sirolimus/therapeutic use	0.0032890445713762	0.0063197351885054	0.021505376344086	0.830190299122522	1	0
immune system diseases/drug therapy	LIF	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
immunocompromised host	immunosuppressive agents/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
immunocompromised host	melanoma/immunology	0	0	0.010752688172043	0.830190299122522	1	0
immunocompromised host	myasthenia gravis/diagnosis	0	0	0.010752688172043	0.830190299122522	1	0
immunocompromised host	prednisone/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
immunocompromised host	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
immunologic memory/drug effects	interferon-gamma/metabolism	2.57265308056809e-07	1.66393968736404e-06	0.010752688172043	0.830190299122522	1	0
immunologic memory/drug effects	phenotype	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
immunologic memory/drug effects	piperidines/therapeutic use	3.67543332718823e-05	0.0001340865542691	0.021505376344086	0.830190299122522	1	0
immunologic memory/drug effects	pyrimidines/therapeutic use	3.67543332718823e-05	0.0001340865542691	0.021505376344086	0.830190299122522	1	0
immunosuppressive agents/pharmacology	infliximab/adverse effects	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
immunosuppressive agents/pharmacology	intestinal mucosa/diagnostic imaging	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
immunosuppressive agents/pharmacology	melanoma/drug therapy	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
immunosuppressive agents/pharmacology	mucositis/chemically induced	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
immunosuppressive agents/pharmacology	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
immunosuppressive agents/therapeutic use	melanoma/immunology	0	0	0.010752688172043	0.830190299122522	1	0
immunosuppressive agents/therapeutic use	myasthenia gravis/diagnosis	0	0	0.010752688172043	0.830190299122522	1	0
immunosuppressive agents/therapeutic use	prednisone/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
immunosuppressive agents/therapeutic use	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
inflammation/drug therapy	melanoma/genetics	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	multigene family	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	myeloid cells/cytology	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	receptors antigen t-cell/genetics	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	receptors cxcr3/genetics	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	receptors cxcr6/genetics	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammation/drug therapy	t-lymphocytes regulatory/cytology	0.0001276936833728	0.00036582514696	0.021505376344086	0.830190299122522	1	0
inflammatory bowel diseases	neoplasms	2.36599509539914e-07	1.53548253129985e-06	0.0846189808321645	0.830190299122522	1	0
inflammatory bowel diseases	programmed cell death 1 receptor/metabolism	1.95732319241415e-13	3.011752138005e-12	0.021505376344086	0.830190299122522	1	0
inflammatory bowel diseases	recurrence	0	0	0.021505376344086	0.830190299122522	1	0
inflammatory bowel diseases/complications	neoplasms/complications	3.03292073455808e-07	1.95500431133e-06	0.0638148667601683	0.830190299122522	1	0
inflammatory bowel diseases/drug therapy	ipilimumab/therapeutic use	0.0036027646835737	0.0067591691408641	0.0946781129109319	0.830190299122522	1	0
inflammatory bowel diseases/drug therapy	proton pump inhibitors/adverse effects	1.25266463868456e-12	1.86725322703918e-11	0.032258064516129	0.830190299122522	1	0
infliximab/administration & dosage	melanoma/complications	8.11373358056144e-07	4.85297920743299e-06	0.032258064516129	0.830190299122522	1	0
infliximab/administration & dosage	urothelium/drug effects	0	0	0.010752688172043	0.830190299122522	1	0
infliximab/adverse effects	intestinal mucosa/diagnostic imaging	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
infliximab/adverse effects	LTF	8.48877190762209e-10	7.74320237197327e-09	0.043010752688172	0.830190299122522	1	0
infliximab/adverse effects	melanoma/drug therapy	2.48187697959867e-06	1.42204843155383e-05	0.0134138885892041	0.584635003932401	2	0
infliximab/adverse effects	mucositis/chemically induced	1.69483587066921e-05	6.44172677537221e-05	0.043010752688172	0.830190299122522	1	0
infliximab/adverse effects	neoplasms	0.0003058560984983	0.0007520276236272	0.163750819851802	0.830190299122522	1	0
infliximab/adverse effects	skin neoplasms/drug therapy	0.0015703678212359	0.0034087164993381	0.0846189808321645	0.830190299122522	1	0
infliximab/adverse effects	steroids/adverse effects	6.36879438076221e-12	9.068402745145e-11	0.043010752688172	0.830190299122522	1	0
interferon-gamma/metabolism	phenotype	0.000124270133592	0.0003619960532727	0.021505376344086	0.830190299122522	1	0
interferon-gamma/metabolism	piperidines/therapeutic use	3.67543332718823e-05	0.0001340865542691	0.021505376344086	0.830190299122522	1	0
interferon-gamma/metabolism	pyrimidines/therapeutic use	3.67543332718823e-05	0.0001340865542691	0.021505376344086	0.830190299122522	1	0
interleukin-12/antagonists & inhibitors	interleukin-23/antagonists & inhibitors	0	0	0.010752688172043	0.830190299122522	1	0
interleukin-12/antagonists & inhibitors	ustekinumab/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	lymphocytes tumor-infiltrating/metabolism	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-17/genetics	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
interleukin-23/antagonists & inhibitors	ustekinumab/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
intestinal mucosa/diagnostic imaging	melanoma/drug therapy	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
intestinal mucosa/diagnostic imaging	mucositis/chemically induced	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
intestinal mucosa/diagnostic imaging	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
intestinal mucosa/immunology	neoplasms/drug therapy	1.4296142507475e-05	5.4994032065045e-05	0.129032258064516	0.830190299122522	1	0
ipilimumab/adverse effects	nivolumab/adverse effects	0	0	2.70981274267652e-06	0.010308700389748	7	0
ipilimumab/adverse effects	protein kinase inhibitors/therapeutic use	8.84097061502054e-05	0.0002777578837603	0.0967741935483871	0.830190299122522	1	0
ipilimumab/therapeutic use	myasthenia gravis/chemically induced	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
ipilimumab/therapeutic use	myocarditis/chemically induced	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
ipilimumab/therapeutic use	nephritis/chemically induced	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
ipilimumab/therapeutic use	pneumonia/chemically induced	2.19354342352318e-05	8.23874183480754e-05	0.0020883744586409	0.584635003932401	2	0
ipilimumab/therapeutic use	proton pump inhibitors/adverse effects	1.4077731091966e-08	9.94826330498929e-08	0.032258064516129	0.830190299122522	1	0
ipilimumab/therapeutic use	pruritus/chemically induced	0.0036027646835737	0.0067591691408641	0.032258064516129	0.830190299122522	1	0
leukocyte l1 antigen complex/analysis	neoplasms/drug therapy	0.0004436759846442	0.0010715617451913	0.129032258064516	0.830190299122522	1	0
ligands	pneumonia	0	0	0.010752688172043	0.830190299122522	1	0
LTF	neoplasms	7.7715611723761e-16	1.66608300189816e-14	0.043010752688172	0.830190299122522	1	0
lung neoplasms	steroids/therapeutic use	0	0	0.021505376344086	0.830190299122522	1	0
lung neoplasms/drug therapy	nivolumab/adverse effects	0.0036027646835737	0.0067591691408641	0.242636746143057	0.830190299122522	1	0
lung neoplasms/drug therapy	prednisolone/therapeutic use	0	0	0.021505376344086	0.830190299122522	1	0
lymphocytes tumor-infiltrating/immunology	MTOR	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/immunology	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/immunology	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/metabolism	micrornas/genetics	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/metabolism	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/metabolism	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/metabolism	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
lymphocytes tumor-infiltrating/metabolism	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
lymphocytes/drug effects	melanoma/complications	2.84150786487025e-05	0.0001046640348681	0.032258064516129	0.830190299122522	1	0
lymphocytes/drug effects	neutrophils/drug effects	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
lymphocytes/drug effects	vitamin d/administration & dosage	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
macrophages/drug effects	phenotype	1.09558519411079e-05	4.30118631762015e-05	0.021505376344086	0.830190299122522	1	0
melanoma/complications	neutrophils/drug effects	2.84150786487025e-05	0.0001046640348681	0.032258064516129	0.830190299122522	1	0
melanoma/complications	skin neoplasms/complications	2.20490292690556e-12	3.23611906502755e-11	0.032258064516129	0.830190299122522	1	0
melanoma/complications	urothelium/drug effects	8.11373358056144e-07	4.85297920743299e-06	0.032258064516129	0.830190299122522	1	0
melanoma/complications	vitamin d/administration & dosage	2.84150786487025e-05	0.0001046640348681	0.032258064516129	0.830190299122522	1	0
melanoma/drug therapy	mucositis/chemically induced	0.0001660054582111	0.0004664777824253	0.053763440860215	0.830190299122522	1	0
melanoma/drug therapy	skin neoplasms/drug therapy	3.54466825891464e-08	2.36476469860459e-07	0.0023375409069658	0.584635003932401	2	0
melanoma/drug therapy	TNF	1.42285160453781e-06	8.30214330721145e-06	0.0068584991446141	0.584635003932401	2	0
melanoma/drug therapy	tumor necrosis factor inhibitors	2.34397230222116e-05	8.71793207141907e-05	0.053763440860215	0.830190299122522	1	0
melanoma/drug therapy	vitamin d	1.59897295404221e-09	1.23515805518726e-08	0.053763440860215	0.830190299122522	1	0
melanoma/genetics	multigene family	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/genetics	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/genetics	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/genetics	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/genetics	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/genetics	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
melanoma/immunology	myasthenia gravis/diagnosis	0	0	0.010752688172043	0.830190299122522	1	0
melanoma/immunology	prednisone/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
melanoma/immunology	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
mesalamine/pharmacology	protective agents/pharmacology	0	0	0.010752688172043	0.830190299122522	1	0
mesalamine/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0	0	0.010752688172043	0.830190299122522	1	0
metabolome/drug effects	neoplasms/complications	5.79199854744417e-09	4.18603531383465e-08	0.032258064516129	0.830190299122522	1	0
micrornas/genetics	MIR15B	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
micrornas/genetics	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
micrornas/genetics	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
micrornas/genetics	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
MIR15B	NRF1	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
MIR15B	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
MIR15B	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
MTOR	phosphatidylinositol 3-kinases/metabolism	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
MTOR	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
mucositis/chemically induced	skin neoplasms/drug therapy	6.08395890666635e-07	3.69687694073866e-06	0.021505376344086	0.830190299122522	1	0
multigene family	myeloid cells/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
multigene family	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
multigene family	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
multigene family	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
multigene family	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myasthenia gravis/chemically induced	myocarditis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
myasthenia gravis/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
myasthenia gravis/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
myasthenia gravis/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
myasthenia gravis/diagnosis	prednisone/therapeutic use	0	0	0.010752688172043	0.830190299122522	1	0
myasthenia gravis/diagnosis	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
myeloid cells/cytology	receptors antigen t-cell/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid cells/cytology	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid cells/cytology	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid cells/cytology	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid-derived suppressor cells/metabolism	PARP1	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid-derived suppressor cells/metabolism	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid-derived suppressor cells/metabolism	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid-derived suppressor cells/metabolism	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myeloid-derived suppressor cells/metabolism	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
myocarditis/chemically induced	nephritis/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
myocarditis/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
myocarditis/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
myocarditis/diagnostic imaging	neoplasms/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
myocarditis/diagnostic imaging	pancreatitis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
myocarditis/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
myocarditis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
myocarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
myocarditis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
neoplasms	recurrence	7.7715611723761e-16	1.66608300189816e-14	0.043010752688172	0.830190299122522	1	0
neoplasms/diagnosis	pneumonia/chemically induced	9.10500023044714e-05	0.0002777578837603	0.032258064516129	0.830190299122522	1	0
neoplasms/diagnostic imaging	pancreatitis/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
neoplasms/diagnostic imaging	pericarditis/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
neoplasms/diagnostic imaging	pneumonia/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
neoplasms/diagnostic imaging	sarcoidosis/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
neoplasms/diagnostic imaging	thyroiditis/diagnostic imaging	2.00646083081679e-08	1.36725973757087e-07	0.021505376344086	0.830190299122522	1	0
neoplasms/drug therapy	protein kinase inhibitors/therapeutic use	0.0012043173595439	0.0026891839170452	0.129032258064516	0.830190299122522	1	0
neoplasms/drug therapy	t-lymphocyte subsets/immunology	1.4296142507475e-05	5.4994032065045e-05	0.129032258064516	0.830190299122522	1	0
neoplasms/drug therapy	tryptophan/pharmacology	0.0001112700446812	0.0003281348458297	0.129032258064516	0.830190299122522	1	0
neoplasms/drug therapy	virus diseases/etiology	0.0012043173595439	0.0026891839170452	0.129032258064516	0.830190299122522	1	0
nephritis/chemically induced	nivolumab/therapeutic use	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
nephritis/chemically induced	pruritus/chemically induced	0.0002334339983105	0.0005814517869145	0.010752688172043	0.830190299122522	1	0
neutrophils/drug effects	vitamin d/administration & dosage	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
nivolumab/adverse effects	oropharyngeal neoplasms/drug therapy	8.27983542073252e-06	3.54050817950207e-05	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	paclitaxel/therapeutic use	0.0036027646835737	0.0067591691408641	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	postoperative complications	8.27983542073252e-06	3.54050817950207e-05	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	prednisolone/therapeutic use	8.27983542073252e-06	3.54050817950207e-05	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	protein kinase inhibitors/therapeutic use	0.000872653019809	0.0020084704002361	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.0036027646835737	0.0067591691408641	0.129032258064516	0.830190299122522	1	0
nivolumab/adverse effects	tongue neoplasms/drug therapy	0.0036027646835737	0.0067591691408641	0.129032258064516	0.830190299122522	1	0
nivolumab/therapeutic use	pruritus/chemically induced	0.00299295859196	0.0058034197088005	0.021505376344086	0.830190299122522	1	0
NRF1	t-lymphocytes cytotoxic/immunology	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
NRF1	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
paclitaxel/therapeutic use	SNCA	2.03116920582946e-06	1.16731049539838e-05	0.032258064516129	0.830190299122522	1	0
paclitaxel/therapeutic use	squamous cell carcinoma of head and neck/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
paclitaxel/therapeutic use	tongue neoplasms/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
pancreatitis/diagnostic imaging	pericarditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pancreatitis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pancreatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pancreatitis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
PARP1	phthalazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
PARP1	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
PARP1	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
PARP1	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
pericarditis/diagnostic imaging	pneumonia/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pericarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pericarditis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
phenotype	piperidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
phenotype	pyrimidines/therapeutic use	0.0022342109308476	0.0044825178297132	0.0427769985974754	0.830190299122522	1	0
phosphatidylinositol 3-kinases/metabolism	sirolimus/therapeutic use	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
phthalazines/administration & dosage	piperazines/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
phthalazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
phthalazines/administration & dosage	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
piperazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
piperazines/administration & dosage	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
piperidines/therapeutic use	protein kinase inhibitors/therapeutic use	1.4077731091966e-08	9.94826330498929e-08	0.021505376344086	0.830190299122522	1	0
piperidines/therapeutic use	pyrimidines/therapeutic use	4.54450921338889e-11	4.9832894133023e-10	0.0002337540906965	0.584635003932401	2	0
pneumonia/diagnostic imaging	sarcoidosis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
pneumonia/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
poly(adp-ribose) polymerase inhibitors/administration & dosage	TIPARP	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
prednisone/therapeutic use	skin neoplasms/immunology	0	0	0.010752688172043	0.830190299122522	1	0
protective agents/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0	0	0.010752688172043	0.830190299122522	1	0
protein kinase inhibitors/therapeutic use	pyrimidines/therapeutic use	1.4077731091966e-08	9.94826330498929e-08	0.021505376344086	0.830190299122522	1	0
psoriasis	rna	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
psoriasis	TCIM	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
psoriasis	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
receptors antigen t-cell/genetics	receptors cxcr3/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
receptors antigen t-cell/genetics	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
receptors antigen t-cell/genetics	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
receptors cxcr3/genetics	receptors cxcr6/genetics	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
receptors cxcr3/genetics	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
receptors cxcr6/genetics	t-lymphocytes regulatory/cytology	8.68426534594846e-06	3.54050817950207e-05	0.010752688172043	0.830190299122522	1	0
rna	TCIM	1.69131375571396e-11	1.90948322242736e-10	0.010752688172043	0.830190299122522	1	0
rna	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
sarcoidosis/diagnostic imaging	thyroiditis/diagnostic imaging	9.98337412738692e-10	7.74320237197327e-09	0.010752688172043	0.830190299122522	1	0
skin neoplasms/drug therapy	SNCA	0.0009302340538402	0.0021230700654632	0.0638148667601683	0.830190299122522	1	0
skin neoplasms/drug therapy	TNF	0.0012219719371479	0.0026891839170452	0.0638148667601683	0.830190299122522	1	0
skin neoplasms/drug therapy	tumor necrosis factor inhibitors	2.25073886195304e-08	1.50681043810751e-07	0.021505376344086	0.830190299122522	1	0
SNCA	squamous cell carcinoma of head and neck/drug therapy	2.03116920582946e-06	1.16731049539838e-05	0.032258064516129	0.830190299122522	1	0
SNCA	TNF	0.0036748977609006	0.0068877258622775	0.0946781129109319	0.830190299122522	1	0
SNCA	tongue neoplasms/drug therapy	2.03116920582946e-06	1.16731049539838e-05	0.032258064516129	0.830190299122522	1	0
SNCA	tumor necrosis factor inhibitors	4.50371576143915e-07	2.87394303438993e-06	0.032258064516129	0.830190299122522	1	0
squamous cell carcinoma of head and neck/drug therapy	tongue neoplasms/drug therapy	6.98330282489224e-14	1.11967578066339e-12	0.010752688172043	0.830190299122522	1	0
t-lymphocytes cytotoxic/immunology	tumor microenvironment/drug effects	9.37505645396408e-05	0.0002777578837603	0.010752688172043	0.830190299122522	1	0
TCIM	TNF	1.09558519411079e-05	4.30118631762015e-05	0.032258064516129	0.830190299122522	1	0
TNF	tumor necrosis factor inhibitors	8.11373358056144e-07	4.85297920743299e-06	0.032258064516129	0.830190299122522	1	0
